Sight Sciences, Inc.
NASDAQ:SGHTMedical - Devices
Healthcare
$10.62 +2.89%
+$0.15 today
- Market cap
- $590.25M
- Beta
- 2.41
- P/E (TTM)
- -7.5
- EPS (TTM)
- -$0.69
52W Low $3.11High $9.24
Volume 0.38M
Average 0.25M
Income Statement
Follow revenue through to earnings.
Revenue
$77.36M
FY 2025 · Annual
-3.1% YoYOperating Income
-$37.10M
FY 2025 · Annual
Net Income
-$38.43M
FY 2025 · Annual
Income Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 48.96M | 71.33M | 81.06M | 79.87M | 77.36M |
| Cost of Revenue | 8.61M | 12.36M | 11.88M | 11.58M | 10.7M |
| Gross Profit | 40.35M | 58.97M | 69.18M | 68.29M | 66.67M |
| Gross Margin | 82.4% | 82.7% | 85.3% | 85.5% | 86.2% |
| Research & Development | 15.63M | 22.86M | 17.56M | 17.99M | 14.61M |
| Selling, General & Admin | 76.19M | 120.07M | 108.89M | 100.83M | 89.16M |
| Operating Expenses | 91.82M | 142.92M | 126.45M | 118.82M | 103.77M |
| Depreciation & Amortization | 1.2M | 1.25M | 614K | 712K | 487K |
| EBITDA | (57.21M) | (80.48M) | (49.42M) | (45.9M) | (32.79M) |
| EBITDA Margin | -116.8% | -112.8% | -61.0% | -57.5% | -42.4% |
| Operating Income | (51.48M) | (83.95M) | (57.27M) | (50.53M) | (37.1M) |
| Operating Margin | -105.2% | -117.7% | -70.7% | -63.3% | -48.0% |
| Interest Income | 0 | 0 | 0 | 0 | 3.97M |
| Interest Expense | 4.37M | 4.47M | 5.41M | 4.66M | 5.14M |
| Other Income / Expenses | (11.29M) | (2.24M) | 1.84M | (739K) | (1.32M) |
| Income Before Tax | (62.77M) | (86.2M) | (55.44M) | (51.27M) | (38.42M) |
| Pre-Tax Margin | -128.2% | -120.8% | -68.4% | -64.2% | -49.7% |
| Income Tax Expense | 188K | 47K | 110K | 236K | 10K |
| Net Income | (62.96M) | (86.24M) | (55.55M) | (51.51M) | (38.43M) |
| Net Margin | -128.6% | -120.9% | -68.5% | -64.5% | -49.7% |
| EPS (Basic) | (1.33) | (1.80) | (1.14) | (1.03) | (0.74) |
| EPS (Diluted) | (1.33) | (1.80) | (1.14) | (1.03) | (0.74) |
| 47.5M | 47.85M | 48.63M | 50.13M | 52.15M | |
| 47.5M | 47.85M | 48.63M | 50.13M | 52.15M |
SGHT Earnings Waterfall · TTM
NASDAQ:SGHT · Revenue to Net Income
Key Ratios
EPS$-0.71
Gross Margin86.2%
Net Margin-47.1%
P/E Ratio-9.8
P/S Ratio12.7
Analysis
$79.6M of revenue converted into -$37.3M of net income for the selected period. Gross margin is 86.2% and net margin is -47.1%, showing how much revenue survives after costs and taxes. EPS is $-0.71, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 5, 2026 |
How much revenue does SGHT generate?
Sight Sciences, Inc. (SGHT) reported $77.36M of revenue in fiscal 2025.
Is SGHT profitable?
Sight Sciences, Inc. (SGHT) reported -$38.43M of net income, with a net margin of -49.7%.
Continue the stock analysis
Jump to another research area for this company.